SOLACI PERIPHERAL | A New SOLACI Department

SOLACI Peripheral

We are pleased to announce the creation of SOLACI’s new Department of Peripheral Endovascular Interventions.

Its name is SOLACI PERIPHERAL and its objectives will be as follows:

  • To promote continuing education for the community of interventional cardiologists involved in peripheral endovascular interventions.
  • To collaborate in the organization of Congress sessions dedicated to peripheral interventions and other SOLACI scientific activities.
  • To promote instances where colleagues can share their experience and knowledge, so that the whole group can experience growth.
  • To act alongside SOLACI RESEARCH (SOLACI’s Department of Research) in the elaboration of scientific studies and registries.

All interventional cardiologists eager to participate who meet the basic requirements below will be added to the department as collaborators.

Basic requirements:

  • Practicing interventional cardiology in Latin America.
  • Showing a desire to help in the development of peripheral interventions.
  • Sending an abridged CV and a description of the peripheral procedures conducted.
  •  

If you want to take part in this new SOLACI initiative, or if you have questions, contact us at periferico@solaci.org

We count on the support of the Latin American medical community as a whole for the development of this new, significant project that will be crucial for the promotion and boost of interventional cardiology in our region.

We count on your collaboration.

Sincerely,

Dr. Maurício Cavalieri Machado
Dr. Maurício Cavalieri Machado Coordinator, Department of Peripheral Endovascular Interventions
 

Dr. José Armando Mangione 
SOLACI President


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....